News
The Hill on MSN3h
FDA commissioner stirs debate over hormone therapy for menopauseA Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response ...
The FDA and Power Stick recalled thousands of deodorant cases because manufacturing practices did not comply with FDA ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results